Medical Equipment

Cardiovascular Surgery Devices And Equipment Market Developments Influencing Industry Expansion Through 2030

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Cardiovascular Surgery Devices And Equipment Market Increase Between 2026 And 2030?

The market for cardiovascular surgery devices and equipment has experienced slight growth over recent years. This market is projected to expand from $1.8 billion in 2025 to $1.82 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 0.7%. Historically, this expansion has been driven by factors such as a greater occurrence of cardiovascular conditions, the proliferation of cardiac surgery procedures, the introduction of sophisticated surgical equipment, an increase in specialized cardiac medical facilities, and the growing uptake of bypass and ablation systems.

The cardiovascular surgery devices and equipment market is expected to demonstrate steady expansion in the upcoming years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%. This projected growth during the forecast period is driven by factors such as an escalating demand for less invasive cardiac procedures, increasing investments in advanced surgical platforms, the expansion of hybrid cardiac operating rooms, the growing adoption of AI-assisted surgical planning, and continuous innovation in cardiovascular surgical devices. Notable trends for the forecast period include the rising acceptance of minimally invasive cardiac surgery devices, an increase in the use of advanced cardiac ablation technologies, enhanced precision in cardiopulmonary bypass systems, the broadening application of beating heart surgery techniques, and a heightened focus on optimizing surgical outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

What Influential Factors Are Boosting The Cardiovascular Surgery Devices And Equipment Market Demand?

The increasing elderly demographic is projected to stimulate the expansion of the cardiovascular surgical devices market moving forward. The geriatric population refers to individuals aged 65 years and older who are considered older adults within a population. They exhibit heightened healthcare demands due to age-related bodily changes and a greater prevalence of chronic health conditions. Cardiovascular surgical devices support the geriatric population by enabling safer, minimally invasive procedures that address age-related heart issues and enhance overall survival and life quality. For example, in October 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, between 2020 and 2050, the count of people 80 years of age or older is expected to treble to 426 million. Therefore, the growing geriatric population is driving the growth of the cardiovascular surgical devices market.

How Is Segment Classification Applied In The Cardiovascular Surgery Devices And Equipment Market?

The cardiovascular surgery devices and equipment market covered in this report is segmented –

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables

2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications

3) By End User: Ambulatory Surgical Centers, Hospitals, Cardiac Specialty Centers, Research Laboratories

Subsegments:

1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices

2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment

3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices

4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables

What Trends Are Influencing The Future Of The Cardiovascular Surgery Devices And Equipment Market?

Major companies are directing investments toward enterprises in the cardiovascular surgery devices and Equipment market that are focused on developing innovative solutions, such as CardioVisio for Atrial Fibrillation (AFib), to enhance early diagnosis, improve patient outcomes, and optimize treatment pathways. CardioVisio for Atrial Fibrillation (AFib) is defined as an advanced diagnostic and monitoring solution engineered to detect and manage AFib, a common type of irregular heart rhythm. For example, in August 2023, GE HealthCare, a US-based medical technology company, introduced CardioVisio for Atrial Fibrillation (AFib). This digital clinical decision support tool is intended to improve precision care for patients with AFib. Launched at the ESC Congress 2023, this innovative solution integrates longitudinal patient data from various sources, offering clinicians a comprehensive view of heart health. By providing evidence-based recommendations that align with AFib guidelines, CardioVisio streamlines clinical workflows and strengthens adherence to best practices.

Who Are The Firms Contributing To The Cardiovascular Surgery Devices And Equipment Market Ecosystem?

Major companies operating in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., TransMedics, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Medtronic plc, Cyberheart Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.p.A., Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., LivaNova PLC, CryoLife Inc., Artivion Inc.

Access The Complete Cardiovascular Surgery Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Which Geographic Region Represents The Largest Cardiovascular Surgery Devices And Equipment Market Share?

North America was the largest region in the global cardiovascular surgery devices and equipment market in 2025. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cardiovascular Surgery Devices And Equipment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Surgery Devices And Equipment Market 2026, By The Business Research Company

Cosmetic Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cosmetic-implants-global-market-report

Smart Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report

Dental Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795